Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▼ |
|---|---|---|---|
| 6ZJM | 6ZJM | Atomic model of Andes virus glycoprotein spike tetramer generated by fitting into a Tula virus reconstruction | Envelope polyprotein,Envelope polyprotein,Envelope polyprotein |
| 6YRB | Q9E006 | Crystal structure of the tetramerization domain of the glycoprotein Gn (Andes virus) at pH 7.5 | Envelope polyprotein,Envelope polyprotein |
| 7B0A | Q9WJ31 | Puumala virus-like particle glycoprotein spike and lattice contacts model. | Envelope polyprotein |
| 6HRO | Q05320 | Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a | Envelope glycoprotein,Envelope glycoprotein,Envelope glycoprotein, Envelope glycoprotein |
| 6G9B | Q05320 | Crystal structure of Ebolavirus glycoprotein in complex with imipramine | Envelope glycoprotein,Envelope glycoprotein, Envelope glycoprotein |
| 6G9I | Q05320 | Crystal structure of Ebolavirus glycoprotein in complex with clomipramine | Envelope glycoprotein,Envelope glycoprotein |
| 6G9I | M1E1E4 | Crystal structure of Ebolavirus glycoprotein in complex with clomipramine | Envelope glycoprotein,Envelope glycoprotein |
| 5HJ3 | 5HJ3 | Crystal structure of host-primed Ebola virus GP, GPcl. | Envelope glycoprotein, KZ52 Antibody Fragment |
| 5HJ3 | Q05320 | Crystal structure of host-primed Ebola virus GP, GPcl. | Envelope glycoprotein, KZ52 Antibody Fragment |
| 5HJ3 | P87666 | Crystal structure of host-primed Ebola virus GP, GPcl. | Envelope glycoprotein, KZ52 Antibody Fragment |
| 6DZM | B8XCN0 | Bundibugyo virus GP (mucin-deleted) in complex with pan-ebolavirus human antibody ADI-15878 Fab | Envelope glycoprotein, Glycoprotein, Antibody ADI-15878 Fab, light chain, Antibody ADI-15878 Fab, heavy chain |
| 6DZM | 6DZM | Bundibugyo virus GP (mucin-deleted) in complex with pan-ebolavirus human antibody ADI-15878 Fab | Envelope glycoprotein, Glycoprotein, Antibody ADI-15878 Fab, light chain, Antibody ADI-15878 Fab, heavy chain |
| 6UM7 | Q2N0S7 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain |
| 6UM7 | A0A1W6IPB2 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain |
| 6UM7 | 6UM7 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain |
| 6UM5 | A0A1W6IPB2 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
| 6UM5 | Q2N0S7 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
| 6UM5 | 6UM5 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
| 6ORP | 6ORP | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP | Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab897NHP antibody Fab heavy chain, Ab897NHP antibody Fab light chain |
| 6ORQ | 6ORQ | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR | Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab275MUR antibody Fab heavy chain, Ab275MUR antibody Fab light chain |
| 6OKP | B3UEZ6 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | B3UES2 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6ORN | 6ORN | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain |
| 6XRT | Q2N0S6 | Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 | Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain |
| 6XRT | 6XRT | Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 | Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain |
| 6NNJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 6NNJ | 6NNJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 6NM6 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 6NM6 | 6NM6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom | Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain |
| 6DFG | Q2N0S6 | BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding | Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain |
| 6DFG | Q2N0S8 | BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding | Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain |
| 6DFG | 6DFG | BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding | Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain |
| 6DFH | Q2N0S6 | BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding | Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain |
| 6DFH | Q2N0S5 | BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding | Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain |
| 6DFH | 6DFH | BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding | Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain |
| 5VN8 | B3UEZ6 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN8 | B3UES2 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN8 | 5VN8 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 6MEO | P01730 | Structural basis of coreceptor recognition by HIV-1 envelope spike | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5 |
| 6MEO | P51681 | Structural basis of coreceptor recognition by HIV-1 envelope spike | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5 |
| 6MEO | Q70145 | Structural basis of coreceptor recognition by HIV-1 envelope spike | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5 |
| 6MET | P01730 | Structural basis of coreceptor recognition by HIV-1 envelope spike | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5 |
